巴西矛头蝮蛇咬伤后血栓性微血管病:病例报告
本文报告一例56岁女性在左下肢远端被巴西矛头蝮蛇咬伤约7小时后转入急诊,出现咬伤部位至大腿近端的肿胀、剧烈放射痛、局部感觉异常和瘀斑。入院时实验室检查显示凝血病(全血凝血时间WBCT20>20分钟)、血小板减少(76,000/mm³)和血清肌酐轻度升高(1.58 mg/dL)。给予抗蛇毒血清和液体补充后,血小板减少和贫血加重,血涂片见破碎红细胞、结合珠蛋白消耗、乳酸脱氢酶升高,血清肌酐进行性升高至KDIGO 3期。未行红细胞输注、肾脏替代治疗或血浆置换,患者从第9天开始逐渐改善,第20天出院,随访第50天血红蛋白完全恢复。
要点
- 巴西矛头蝮蛇咬伤后约7小时可出现凝血病(WBCT20>20分钟)、血小板减少(76,000/mm³)和血清肌酐升高(1.58 mg/dL)。
- 病程中血小板减少和贫血加重,血涂片见破碎红细胞、结合珠蛋白消耗、乳酸脱氢酶升高,血清肌酐进行性升高至KDIGO 3期。
- 尽管病情严重,未行红细胞输注、肾脏替代治疗或血浆置换,保守治疗后患者从第9天开始改善,第20天出院。
- 随访第50天血红蛋白完全恢复,咬伤后10个月检测ADAMTS-13活性在参考值范围内。
适用人群与场景
- 被巴西矛头蝮蛇咬伤的患者,咬伤部位为左下肢远端。
诊断标准与关键阈值
- 血栓性微血管病诊断依据:微血管病性溶血性贫血、血小板减少和急性肾损伤三联征,类似溶血性尿毒症综合征。
- 入院时实验室阈值:全血凝血时间WBCT20>20分钟,血小板76,000/mm³,血清肌酐1.58 mg/dL(参考值<1.2 mg/dL)。
- 血清肌酐进行性升高至KDIGO 3期。
处置流程与药物剂量
- 入院后给予抗蛇毒血清和液体补充治疗。
- 未行红细胞输注、肾脏替代治疗或血浆置换。
研究设计与关键结果
- 病例报告:56岁女性,有控制良好的高血压,被巴西矛头蝮蛇咬伤左下肢远端约7小时后转入急诊。
- 入院时出现咬伤部位至大腿近端的肿胀、剧烈放射痛、局部感觉异常和瘀斑。
- 入院实验室检查:WBCT20>20分钟,血小板76,000/mm³,血清肌酐1.58 mg/dL(参考值<1.2 mg/dL)。
- 病程中血小板减少和贫血加重,血涂片见破碎红细胞、结合珠蛋白消耗、乳酸脱氢酶升高,血清肌酐进行性升高至KDIGO 3期。
- 未行红细胞输注、肾脏替代治疗或血浆置换,患者从第9天开始逐渐改善,第20天出院。
- 随访第50天血红蛋白完全恢复;咬伤后10个月检测ADAMTS-13活性在参考值范围内。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 巴西矛头蝮蛇咬伤后应监测凝血病、血小板减少和急性肾损伤,警惕血栓性微血管病。
- 作者报告该例患者尽管病情严重,保守治疗(抗蛇毒血清和液体补充)后结局良好,完全康复。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Thrombotic microangiopathy (TMA) is an uncommon and severe complication of snakebites, and is similar, in general, to hemolytic-uremic syndrome (HUS). We describe a case of TMA following envenomation by Bothrops jararaca.
CASE DETAILS: A 56-y-old-woman with controlled hypertension was transferred from a primary hospital to our ER ∼7 h after being bitten by B. jararaca in the distal left leg. She developed edema extending from the bite site to the proximal thigh, associated with intense radiating local pain, local paresthesia and ecchymosis at the bite site. Laboratory features upon admission revealed coagulopathy (20 min whole blood clotting time - WBCT20 > 20 min), thrombocytopenia (76,000 platelets/mm3) and slight increase in serum creatinine (1.58 mg/dL; RV < 1.2 mg/dL). Upon admission, the patient was treated with bothropic antivenom and fluids replacement. During evolution, her thrombocytopenia and anemia worsened, with blood films showing fragmented red cells, haptoglobin consumption, increase in serum lactate dehydrogenase, and progressive increase of serum creatinine (KDIGO stage = 3). No RBC transfusion, renal replacement therapy or plasmapheresis was done. The patient showed progressive improvement from day nine (D9) onwards and was discharged on D20; there was complete recovery of hemoglobin levels at follow-up (D50). ADAMTS-13 activity, assayed 10 months post-bite, was within reference values.
DISCUSSION: TMA following snakebite has been reported mainly in India, Sri Lanka and Australia, with several patients needing renal replacement therapy. Although controversial, plasmapheresis has also been used in some cases. Our patient developed microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury, a triad of features compatible with TMA similar to HUS. Despite the severity, the outcome following conservative treatment was good, with complete recovery.
参考来源
- Bucaretchi F, Pimenta MMB, Borrasca-Fernandes CF, et al. Thrombotic microangiopathy following Bothrops jararaca snakebite: case report. Clin Toxicol (Phila). 2018. PMID: 30444155. doi:10.1080/15563650.2018.1514621
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。